SABRINA: Phase 3 study comparing subcutaneous and intravenous rituximab in follicular lymphoma | Dr Andrew Davies at EHA 2015

At the 20th Congress of the European Hematology Association (EHA), Andrew Davies, BSc (Hons), BM (Hons), MRCP, PhD, of the University of Southampton, Southampton, UK, provides an update on the safety ... Author: EMJ Added: 06/29/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts